Developing a collection of clinical, imaging and biologic specimens to identify biological
markers of Parkinson’s risk, onset and progression
Does collecting data from participants with Parkinson's Disease allow identification
of markers of disease?
Basic Study Information
Purpose:Location: University of Rochester
The Parkinson Progression Marker Initiative 2.0 (PPMI 2.0) is a longitudinal, observational,
multi-center natural history study to assess progression of clinical features, digital
outcomes, and imaging, biologic and genetic markers of Parkinson's disease (PD) progression
in study participants with manifest PD, prodromal PD, and healthy controls.
The overall goal of the study is to identify markers of disease progression for use
clinical trials of therapies to reduce progression of PD disability.
Study Reference #: STUDY00005089
Lead Researcher (Principal Investigator)
Study Contact InformationStudy Coordinator: Sreesravya Betha
Phone: (585) 341-7579
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search